DexCare

DexCare

Software Development

Seattle, WA 6,043 followers

Partnering with health systems to find time at the intersection of demand and access

About us

Incubated at Providence, one of the nation’s largest health systems, DexCare is a data-driven intelligence company focused on making access to healthcare better for everyone. DexCare’s core offering is a software platform, provided exclusively to health systems, that orchestrates digital demand and health system capacity across all lines of care. The platform attracts high-value, commercially-insured consumers by providing a highly discoverable, fully-digitized and unified experience while amplifying health systems’ existing EMR, caregiver and brand investments. The uniqueness of DexCare lies within its intelligent navigation and load balancing across providers, settings, modalities and service lines. DexCare’s data-driven engine allocates, flexes and optimizes resources to best meet both consumer demand and health system business goals. DexCare powers the digital engine of leading health systems across the U.S., including Kaiser Permanente, Houston Methodist, Mass General Brigham and others. DexCare-powered digital experiences attract 30% more new patients, 85% of whom are commercially insured, capture 8x downstream revenue, generate over 20% per patient encounter in cost savings, and deliver net promoter satisfaction greater than 90%.

Website
http://www.dexcare.com
Industry
Software Development
Company size
51-200 employees
Headquarters
Seattle, WA
Type
Privately Held
Founded
2021
Specialties
Healthcare Technology, Enterprise Cloud SaaS, patient acquisition, appointment scheduling, Navigation to best care, patient retention, virtual care, health system digital transformation, patient access, health system capacity optimization, patient engagement, Digital Health Platform, telehealth, patient-provider matching, and patient experience

Products

Locations

Employees at DexCare

Updates

Similar pages

Browse jobs

Funding

DexCare 3 total rounds

Last Round

Series C

US$ 75.0M

See more info on crunchbase